Urinary tract infection in surgical patients

American Journal of Surgery

Volumn 186, Issue 1, 2003, Pages 53-56

  Hashmi, Syed ^a,b   Kelly, Edward ^a   Rogers, Selwyn O ^a   Gates, Jonathan ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Review; Silver coated catheters; Surgery; Urinary catheters; Urinary tract infections

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFOTOXAMINE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; METHENAMINE; NEOMYCIN; PENICILLIN DERIVATIVE; PIPERACILLIN; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; HUMAN; INFECTION CONTROL; MORBIDITY; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; URINARY TRACT INFECTION; URINE CATHETER;

EID: 0038798525     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(03)00120-X     Document Type: Review

References (53)

1. Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR Morb Mortal Wkly Rep 1992;41:783-7.
2. Haley R.W., Hooton T.M., Culver D.H., et al. Nosocomial infections in US hospitals, 1975-76 estimated frequency by selected characteristics of patients . Am J Med. 70:1981;947-959.
3. Krieger J.N., Kaiser D.L., Wenzel R.P. Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis. 148:1983;57-62.
4. Hartstein A.I., Garber S.B., Ward T.T., et al. Nosocmial urinary tract infection a prospective evaluation of 108 catheterized patients . Am J Med. 70:1981;947-959.
5. Bryan C.S., Reynolds K.L. Hospital acquired bacteremic urinary tract infection epidemiology and outcome . J Urol. 132:1984;494-498.
6. Platt R., Polk B.F., Murdock B., Rosner B. Reduction of mortality associated with urinary tract infections. Lancet. 1:1983;893-897.
7. Classen D. Assessing the adverse hospital events on the cost of hospitalization and other patient outcomes. 1993;University of Utah, Salt Lake City.
8. Pories S.E., Gamelli R.L., Mead P.B., et al. The epidemiologic features of nosocomial infections in patients with trauma. Arch Surg. 126:1991;97-99.
9. Garibaldi R.A., Burke J.P., Britt M.R., et al. Meatal colonization and catheter associated bacteriruia. N Engl J Med. 303:1980;316.
10. Schaeffer A.J., Chmiel J. Urethral meatal colonization in the pathogenesis of catheter-associated bacteriuria. J Urol. 130:1983;1096-1099.
11. Menninger M. Urosepsis. Klink, diagnostik, therapie, kapital. Hofstellar A. Urogentilale Infektionen. 1998;521-536 Springer Verlag, Berlin.
12. Mobley H.L., Chippendale G.R., Tenney J.H., et al. MR/K hemagglutination of Providencia stuarti correlates with persistence in catheter associated bacteruria. J Infect Dis. 157:1988;264.
13. Saint S., Wiese J., Amory J.K., et al. Are physicians aware which of their patients have an indwelling urinary catheter? Am J Med. 160:2000;678-682.
14. Jain P, Pavada JP, David A, Smith LG. Overuse of the indwelling urinary catheter in hospitalized medical patients. Arch Intern Med 1995:1425-9.
15. Tambyah P., Maki D. Catheter-associated urinary tract infection is rarely symptomatic a prospective study of 1497 catheterized patients . Arch Intern Med. 160:2000;678-682.
16. Orr P.H., Nicolle L.E., Duckworth H., et al. Febrile urinary tract infection in the institutionalized elderly. Am J Med. 100:1996;1001-1006.
17. O'Grady N.P., Barie P.S., Bartlett J., et al. Practice parameters for evaluating new fever in the critically ill adult patients. Crit Care Med. 26:1998;392-408.
18. Tambyah P.A., Maki D.G. The relationship between pyuria and infection in patients with indweling urinary catheters a prospective study of 761 patients . Arch Intern Med. 160:2000;673-677.
19. Garner J.S., Jarvis W.R., Emori T.G., et al. CDC definitions for nosocomial infections. Am J Infect Control. 16:1988;128-140.
20. Stark R.P., Maki D.G. Bacteruira in the catheterized patient what quantitative level of bacteruria is relevant? N Engl J Med. 311:1984;560-564.
21. Harding G.K.M., Nicolle L.E., Ronald A.R., et al. How long should catheter acquired urinary tract infection in women be treated. Ann Intern Med. 114:1991;713-719.
22. Hartstein AI, Garber, SB, Ward TT, et al. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infect Control 1981;2:380-6.
23. Wagenlehner F.M.E., Naber K.G. Hospital acquired urinary tract infections. J Hosp Infect. 46:2000;171-181.
24. Stamm W.E., Hooten T.M. Management of urinary tract infections in adults. N Engl J Med. 329:1993;1328-1332.
25. Kumazawa J., Matsumoto T. The dipstick test in the diagnosis of UTI and the effect of pretreatment catheter exchange in catheter-associated UTI. Infection. 3:(suppl):1992;157-159.
26. Nickel J.C., Gristina P., Costerton J.W. Electron microscopy of an infected Foley catheter. Can J Surg. 28:1985;50-52.
27. Wise G.J., Silver D.A. Fungal infections of the genitourinary system. J Urol. 149:1993;1377-1388.
28. Rex J.H., Walsh T.H., Sobel J.D., et al. Practice guidelines for the treatment of Candidiasis. Clin Infect Dis. 30:2000;662-678.
29. Sobel J.D., Kaufman C.A., McKinsey D., et al. Candiduria a radomized double-blind study of treatment with fluconazle and placebo . Clin Infect Dis. 30:2000;19-24.
30. Leu H.S., Huang C.T. Clearance of funguria with short-course antifungal regimens a prospective, randomized, controlled study . Clin Infect Dis. 20:1995;1152-1157.
31. Platt R., Polk B.F., Murdock B., Rosner B. Risk factors for nosocomial urinary tract infection. Am J Epidemiol. 124:1986;977-985.
32. Warren J.W. Catheter associated urinary tract infections. Infect Dis Clin North Am. 11:1997;609-622.
33. Meares E.M. Current patterns in nosocomial urinary tract infections. Urology. 37:1991;9-12.
34. Schiotz H.A., Guttu K. Value of urinary prophylaxis with methenamine in gynecolgic surgery. Acta Obstet Gynecol Scand. 81:2002;743-746.
35. Fishman I.J., Santos-Mendoza N. Prevention of urinary tract infection during intermittent catheterization. J Urol. 131:1984;82-85.
36. Cravens D.P., Zweig S. Urinary catheter management. Am Fam Phys. 61:2000;369-376.
37. Kunin C.M., McCormack R.C. Prevention of catheter-induced urinary tract infection by sterile closed drainage. N Engl J Med. 274:1966;1155-1161.
38. Montgomerie J.Z., Morrow J.W. Long term Pseudomonas colonization in spinal cord injury patients. Am J Epidemiol. 112:1980;508-517.
39. Dudley M.N., Barriere S.L. Antimicrobial irrigations in the prevention and treatment of catheter related urinary tract infection. Am J Hosp Pharm. 38:1981;59-65.
40. Gillespie W.A., Simpson R.A., Jones J.E., et al. Does the addition of disinfectant to urine drainage bags prevent infection in catheterized patients? Lancet. 1:1983;1037-1039.
41. Akiyama H., Okamoto S. Prophylaxis of indwelling urethral catheter infection clinical experience with a modified Foley catheter and drainage system . J Urol. 121:1979;40-42.
42. Gabriel M.M., Mayo M.S., May L.L., et al. In-vitro evaluation of the efficacy of a silver-coated catheter. Curr Microbiol. 33:1996;1-5.
43. Saint S., Elmore J.G., Sullivan S.D., et al. The efficacy of silver alloy coated urinary catheters in preventing urinary tract infection a meta-analysis . Am J Med. 105:1998;236-241.
44. Karchmer T.B., Giannetta E.T., Muto C.A., et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 160:2000;3294-3298.
45. Maki D.G., Knasinski V., Halvorson K., et al. A novel silver hydrogel-impregnated indwelling urinary catheter reduces CAUTIS a prospective double blind trial . [abstract] Infect Control Hosp Epidemiol. 19:1998;682.
46. Saint S., Elmore J.G., Sullivan S.D., et al. The efficacy of silver alloy coated urinary catheters in preventing urinary tract infection a meta-analysis . Am J Med. 105:1998;236-241.
47. Saint S., Veenstra D.L., Sullivan S.D., et al. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med. 160:2000;2670-2675.
48. Thibon P., Le Coutour X., Leroyer R., Fabry J. Randomized multicenter trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital acquired urinary tract infections. J Hosp Infect. 45:2000;117-124.
49. Bologna RA, Le Mai TU, Polansky M, et al. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology 1999;982-7.
50. Veryleyen P, DeRidder D, Van Poppel, Baert L. Clinical application of the Bardex IC Foley catheter. Eur Urol 1999;36:240-6.
51. Darouiche R.O., Smith J.A., Hanna H., et al. Efficacy of antimicrobial-impreganted baldder catheters in reducing catheter-associated bacteruria a prospective, randomized, multicenter trial . Urology. 54:1999;976-981.
52. Saint S. Prevention of nosocomial urinary tract infections. Shojania K.G., Duncan B.W., McDonald K.M., Warder R.M. Making health care safer: a clinical analysis of patient safety practices. 2001;149-162 AHRQ Publication No. 01-E058, Rockville, MD.
53. Beeson P.B. The case against the catheter. Am J Med. 24:1958;1-3.